Detalhe da pesquisa
1.
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
Am J Hematol
; 99(7): 1240-1249, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586986
2.
Age-related immune cell dynamics influence outcomes after allogeneic haematopoietic cell transplantation.
Br J Haematol
; 202(1): 122-134, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37092504
3.
A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Cytotherapy
; 25(8): 877-884, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178096
4.
Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study.
Cytotherapy
; 20(4): 524-531, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496461
5.
[Organizational and budgetary impacts of the implementation of CAR-T cell therapies in a French academic hospital]. / Impacts organisationnels et budgétaires de la mise en place des thérapies CAR-T cells au sein d'un centre hospitalier académique français.
Bull Cancer
; 110(12): 1260-1271, 2023 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-37679208
6.
Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoietic stem cell transplantation.
Front Immunol
; 14: 1028162, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36936953
7.
[Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)]. / Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC.
Bull Cancer
; 110(2S): S97-S107, 2023 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-36658011
8.
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
Am J Hematol
; 92(6): E105-E107, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295510
9.
Early 18F-FDG PET Flare-up Phenomenon After CAR T-Cell Therapy in Lymphoma.
Clin Nucl Med
; 47(2): e152-e153, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406181
10.
Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma.
J Clin Med
; 11(21)2022 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36362802
11.
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 22(1): 34-43, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34456160
12.
[Medium-term follow-up of patients treated with chimeric antigen receptor T cells (CAR T cells): Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Suivi au moyen-terme des patients faisant l'objet d'un traitement par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 108(12S): S65-S71, 2021 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-33678408
13.
[Use of the multiparametric panel CD3/CD4/CD8/CD7/CD26/CD158k in the detection and use of flow cytometry of Sezary cells]. / Apport du panel multiparamétrique CD3 CD4 CD8 CD7 CD26 CD158k dans la détection et le suivi par cytométrie en flux des cellules de Sézary.
Ann Biol Clin (Paris)
; 79(3): 233-240, 2021 Jun 01.
Artigo
em Francês
| MEDLINE | ID: mdl-34165432
14.
Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation.
Leuk Lymphoma
; 65(2): 283-286, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990507
15.
Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial.
J Hematol Oncol
; 10(1): 102, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482908